Article
Increase in cerebrospinal fluid F2-isoprostanes is related to cognitive decline in APOE ε4 carriers.
Journal of Alzheimer's disease : JAD - 1 Jan 2013
Duits Flora H, Kester Maartje I, Scheffer Peter G, Blankenstein Marinus A, Scheltens Philip, Teunissen Charlotte E, van der Flier Wiesje M
Abstract excerpt
In this longitudinal study we investigated the effect of apolipoprotein E (APOE) genotype on the relation between cognitive decline and cerebrospinal fluid (CSF) F2-isoprostanes, the reference marker for oxidative stress. Twenty non-demented subjects, 58 mild cognitive impairment (MCI) patients, and 63 Alzheimer's disease (AD) patients with measurements of CSF F2-isoprostanes at two time points (with a mean...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
